Go Pro
→ Why major institutions are piling into this digital asset now (From Awesomely) (Ad)tc pixel
LON:HLN

Haleon Final Earnings Report

Haleon logo
GBX 342.70 -2.20 (-0.64%)
As of 09/25/2026 12:05 PM Eastern
ProfileEarnings HistoryForecast

Haleon EPS Results

Actual EPS
GBX 18.60
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Haleon Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Haleon Announcement Details

Quarter
Final
Date
2/26/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Haleon Earnings Headlines

Haleon Turns to Weight-Loss Drug Users for its Next U.S. Growth Opportunity
September 21, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/news/haleon-turns-to-weight-loss-drug-users-for-its-next-u-s-growth-opportunity-1841720/
Haleon is gaining from the side effects of weight-loss drugs
September 18, 2026  |  msn.comhttps://www.msn.com/en-us/news/money/haleon-is-gaining-from-the-side-effects-of-weight-loss-drugs/ar-AA2cxjUA
First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel
 |  Stansberry Research (Ad)
Haleon Discloses Director Share Purchase via Dividend Reinvestment
September 18, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-discloses-director-share-purchase-via-dividend-reinvestment?utm_source=marketbeat.com&utm_medium=referral
Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs
September 16, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/advil-maker-haleon-boosts-us-sales-by-targeting-consumers-on-weight-loss-drugs/ar-AA2clx7e
Deutsche Bank Reaffirms Their Sell Rating on Haleon PLC (HLN)
September 10, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HLN/pressreleases/4536460/deutsche-bank-reaffirms-their-sell-rating-on-haleon-plc-hln/
See More Haleon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Haleon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Haleon and other key companies, straight to your email.

About Haleon

Haleon (LON:HLN) (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

View Haleon Profile
Earnings Tools